Jeffrey Skolnik, MD

Home » Research » Advisory Councils » Jeffrey Skolnik, MD
Jeffrey Skolnik, MD


Vice President, Clinical Development

Inovio Pharmaceuticals Inc.

Dr. Skolnik is Vice President of Clinical Development for Inovio Pharmaceuticals and prior to that was Chief Medical Officer and VP of Clinical Research for TetraLogic Pharmaceuticals, as well as a US Medical Affairs lead in Oncology for GSK, and clinical lead physician for several pivotal oncology programs at AstraZeneca. Dr. Skolnik is a practicing pediatric hematologist-oncologist with experience in both large pharmaceutical and small biotechnology companies. Dr. Skolnik has experience with both early and late-stage clinical development and extensive experience in developing oncology drug programs for children. Dr. Skolnik previously served as chair of a Children's Oncology Group study, and has several peer-reviewed publications, one of which serves as the basis for novel trial design methodology in the pediatric oncology space.

Pin It on Pinterest

Scroll to Top